As In­dia grows its bi­o­log­ics mar­ket, Ara­gen builds new $30M fa­cil­i­ty

Ara­gen Life Sci­ences is launch­ing a new $30 mil­lion bi­o­log­ics man­u­fac­tur­ing site in Ban­ga­lore due to grow­ing de­mand, the In­dia-based drug man­u­fac­tur­er said Mon­day.

The com­pa­ny’s new 160,000-square-me­ter site will house process de­vel­op­ment labs and GMP man­u­fac­tur­ing suites for the pro­duc­tion of mon­o­clon­al an­ti­bod­ies, ther­a­peu­tic pro­teins and fu­sion pro­teins. The process de­vel­op­ment lab will go on­line some­time be­tween Ju­ly and Sep­tem­ber next year, and the first man­u­fac­tur­ing suite will open in the third quar­ter of 2025.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER